ZYUS

ZYUS Life Sciences Inc is a biopharmaceutical company based in Saskatoon, Canada, that specializes in the development and commercialization of cannabinoid-based therapeutics and phyto-therapeutic compounds. Founded in 2018, the company focuses on providing innovative medical solutions aimed at alleviating suffering for patients dealing with chronic diseases, treatment side effects, and age-related conditions. ZYUS strives to promote cannabinoids as standard medical treatments, emphasizing overall well-being rather than solely addressing physical ailments. As a licensed producer and distributor of medical cannabis in Canada, ZYUS aims to accelerate the adoption of phytotherapeutics in healthcare, utilizing scientific research to support its commitment to improve patient care and quality of life.

Scott Livingstone

Vice President of Clinical Research

3 past transactions

Phoenix Canada Oil

Acquisition in 2023
Phoenix Canada Oil Company Limited, established in 1944 and headquartered in Toronto, Canada, operates primarily in the oil and gas sector. The company has historically focused on the development, production, and maintenance of oil and natural gas properties in western Canada and South America. Currently, Phoenix is shifting its emphasis toward clean energy solutions, particularly in developing water-derived hydrogen technologies. Through its subsidiary, Phoenix International Energy, Inc., the company holds global development rights to a patented hydrogen gas generation technology and is collaborating with academic teams in Canada to scale this technology for commercial use. Additionally, Phoenix engages in research and development with Canadian universities and government institutions to create synthetic hydrocarbon fuels derived from water-based hydrogen.

Revon Systems

Acquisition in 2019
Revon Systems is a developer of a platform for connecting physicians and patients. It offers a web platform that allows physicians to deliver care to patients remotely, specializes in helping patients with cardiovascular and lung conditions to self-manage signs and symptoms, intervene early on health decline that enables patients to manage their health and improve quality of life.

Ehave - Platform

Acquisition in 2019
Ehave - Platform contains components specifically designed to be used by medical cannabis patients to efficiently gather and verify patient-reported outcomes and experiences, evaluate treatment progress, enhance patient engagement and improve data modeling.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.